Accordingly, 56% of patients with truncating ARMC5 variants are primarily referred to clinical departments in front of overt signs of Cushing’s syndrome, versus only 21% of patients with non-truncating pathogenic variants, for which the incidental diagnosis in abdominal imaging is far more frequent [20]. This evidence concerns the gene ARMC5 and Cushing syndrome.